Guo Tai Medical - Current Market Situation Research on Intravenous Catheters
Company overview
Guo Tai Medical is an integrated healthcare service enterprise centered on medicine, supported by big data and intelligent medical technologies, dedicated to providing comprehensive solutions for grassroots healthcare systems. Over the past 17 years, the company has consistently focused on healthcare services, health education, and nursing training, with its 'Good Doctor' and 'Good Health' brands achieving widespread recognition and positive reputation across the country. These brands have established long-term partnerships with numerous grassroots medical institutions, health and wellness commissions, and hospitals. As national policies promoting tiered medical care and enhancing grassroots healthcare capabilities are implemented more deeply, Guo Tai Medical is actively expanding its range of new medical products and services, accelerating the construction of a closed-loop medical and health industry ecosystem.
Research background
Intravenous catheters, as essential medical devices for clinical infusion therapy, offer advantages such as fewer puncture attempts, low infection rates, and ease of use, and have gradually replaced traditional infusion needles and are now widely used in hospitals and grassroots medical institutions. In recent years, with the rapid growth of healthcare demand, increased patient safety awareness, and strengthened policy regulations on the standardization of single-use medical supplies, the intravenous catheter market has shown steady expansion. To align with market trends and expand its product portfolio in medical devices, Guo Tai Medical intends to evaluate the feasibility and strategic pathways for entering the intravenous catheter market. To minimize trial-and-error risks and identify key market entry points, the company has commissioned a third-party research institution to conduct a specialized market study.
Research scope
In August 2015, CEIDEA Research was commissioned by Guo Tai Medical to conduct a focused study on the Chinese intravenous catheter market. The research employed a combined approach of 'macro-level data analysis, expert interviews, and patient interviews,' examining multiple dimensions including industry chain structure, market size, policy environment, technical barriers, competitive landscape, product distribution channels, and clinical usage scenarios. At the macro level, the study analyzed the development history, policy directions, and market trends of intravenous catheters both domestically and internationally. At the expert level, interviews were conducted with frontline clinicians, nursing department directors, and medical supply procurement officers to gather feedback on product usage, procurement logic, and substitution trends. At the end-user level, patient interviews were conducted to understand their experiences, acceptance levels, and perceptions of safety regarding intravenous catheters.
Expected outcomes
This research is expected to provide Guo Tai Medical with a comprehensive understanding of the current market structure, growth opportunities, and entry barriers in the Chinese intravenous catheter market, identifying key success factors and the strategic positioning of leading players. The research report will evaluate the alignment of various market entry strategies—such as in-house production, outsourcing partnerships, or channel acquisitions—and assess the feasibility and implementation pathways for each. It will also propose actionable recommendations on product positioning, distribution models, and differentiated competitive strategies, providing Guo Tai Medical with solid data support and decision-making insights for a scientifically sound entry into the intravenous catheter market.
Scan to add our research consultant